J Korean Soc Radiol.
2024 Nov;85(6):1200-1208. 10.3348/jksr.2024.0023.
Hyperperfusion Syndrome Following Tissue Plasminogen Activator Administration: A Case Report with Radiological Evidence
- Affiliations
-
- 1Department of Radiology, Kangwon National University Hospital, Chuncheon, Korea
- 2Departments of Radiology, College of Medicine, Kangwon National University, Chuncheon, Korea
- 3Departments of Neurology, College of Medicine, Kangwon National University, Chuncheon, Korea
- KMID: 2561710
- DOI: http://doi.org/10.3348/jksr.2024.0023
Abstract
- Cerebral hyperperfusion syndrome is a rare complication that can occur following carotid artery revascularization procedures in patients with chronic carotid artery stenosis. Cases of hyperperfusion syndrome resulting solely from intravenous tissue plasminogen activator administration, without a history of revascularization, are extremely rare. Only four of such cases have been reported with imaging evidence. This report presents a case of early neurological deterioration in acute ischemic stroke, identified as a form of hyperperfusion syndrome. Imaging evidence supports this diagnosis, and highlights the occurrence of hyperperfusion syndrome after intravenous tissue plasminogen activator administration.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Effect of immune-mediated vascular injury on the coagulation- regulatory mechanism of the human endothelial cells; changes of tissue-type plasminogen activator, plasminogen activator inhibitor- 1 and von Willebrand factor
- The treatment of the pulmonary embolism with tissue plasminogen activator: A case report
- Effects of the dosing regimen of tissue-type plasminogen activator on blood coagulation system in experimental pulmonary embolism
- Tissue Plasminogen Activator for Treatment of Subretinal Hemorrhage
- Urokinase-type plasminogen activator receptor in IgA nephropathy
